Khaitan Amarchand AZB and Herbert Smith lead on Claris JV with Otsuka Pharma and Mitsui

Khaitan Amarchand AZB and Herbert Smith lead on Claris JV with Otsuka Pharma and Mitsui
Published on
1 min read

Otsuka Pharmaceutical and Mitsui & Co. have invested Rs. 1050 crore ($193.5 million) in Claris Specialty Injectables, a subsidiary of Ahmedabad-based Claris Lifesciences to form a 3-way strategic joint venture between Otsuka, Mitsui and Claris.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com